Status:
COMPLETED
The Behavioral Effects of Opioids and Alcohol
Lead Sponsor:
Sharon Walsh
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use
Alcohol Drinking
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
Brief Summary
This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings ...
Eligibility Criteria
Inclusion
- Healthy adults ages 21-55
- Current non-medical use of opioids
- Previous alcohol use
Exclusion
- Physical dependence on opioids, alcohol, or benzodiazepines/sedative/hypnotics
- Seeking treatment for drug use
- Significant medical problems
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04300751
Start Date
March 24 2021
End Date
November 9 2024
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40508